Your trusted source for investing success

Tag: lexaria

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
 
Lexaria Featured on NetworkNewsWire

Lexaria Featured on NetworkNewsWire

Lexaria Bioscience (CSE:LXX,OTCQB:LXRP) was featured in a NetworkNewsWire article regarding company’s development and out-licenses of its disruptive patented technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules.

2017 Wrap-Up by Lexaria’s CEO

2017 Wrap-Up by Lexaria’s CEO

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”) announces it’s been quite an amazing year for Lexaria stakeholders – the busiest and most productive we’ve had. I’ve welcomed so many new shareholders and Lexaria fans in 2017 and I want to ensure both our new followers as well as our

Lexaria Bioscience Files S4 Prospectus to Re-Domicile To Canada

Lexaria Bioscience Files S4 Prospectus to Re-Domicile To Canada

Lexaria Bioscience Corp. (OTCQX:LXRP,CSE:LXX) (the ”Company” or ”Lexaria”) announces that, on January 5, 2018, it filed a registration statement and shareholder information circular on Form S-4 with the US Securities and Exchange Commission (the ”SEC”) pursuant to which Lexaria will seek shareholder approval to change its corporate domicile from the

Lexaria Upgrades to the OTCQX Market

Lexaria Upgrades to the OTCQX Market

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has qualified and is now trading on the OTCQX Best Market, operated by OTC Markets Group.

The OTCQX market is reserved for proven companies that meet stringent financial standards, provide thorough and timely news disclosure

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(tm) Delivery of THC, NSAIDs, Nicotine and Vitamins

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces the United States Patent and Trademark Office (“USPTO”) has granted patent number 9,839,612 B2 for the use of DehydraTECHTM technology as a delivery platform for a wide variety of Active Pharmaceutical Ingredients (“APIs”)

Biotech Stocks in 2018


Find out how the market will look this year


Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: Two Provinces Reveal Deals in Place for Recreational Market

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/